Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Cognitive Function in Type 2 Diabetes and Early Alzheimer's Disease
DRKS00003133Phase 2Terminated
- Sponsor
- Universitätsmedizin Essen
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of insulin aspart in type 2 diabetes mellitus (T2DM), Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by Universitätsmedizin Essen. Started Jun 2011; status: terminated.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on DRKS00003133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003133.